UMB, Serenta License Agreement Welcomed in Quest To Combat Deadly Antibiotic-Resistant Staph Infections
University of Maryland, BaltimoreUMB grants licensing rights for new vaccine candidate to Serenta Biotechnology, LLC, whose co-founder, Mark Shirtliff, PhD, professor at the University of Maryland School of Dentistry and the UM School of Medicine.